Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Infrared Spectrometry Method Used for Triage of Brain Cancer Patients

By LabMedica International staff writers
Posted on 23 Oct 2019
A team of British researchers has adapted an advanced spectrophotometric method for use in brain cancer testing as a triage tool to speed up the diagnostic process.

Non-specific symptoms, as well as the lack of a cost-effective test to triage patients in primary care, has resulted in increased time-to-diagnosis and a poor prognosis for brain cancer patients. More...
A rapid, cost-effective, triage test could significantly improve this scenario.

Towards this end, investigators at the University of Strathclyde (Glasgow, United Kingdom), the spinoff biotechnology company ClinSpec Diagnostics Limited (Glasgow, United Kingdom), and colleagues at other institutions developed instrumentation based on testing blood samples by attenuated total reflection (ATR)-Fourier transform infrared (FTIR) spectroscopy to differentiate cancer and control patients.

Fourier-transform infrared spectroscopy (FTIR) is a technique used to obtain an infrared spectrum of absorption or emission of a solid, liquid, or gas. An FTIR spectrometer simultaneously collects high-spectral-resolution data over a wide spectral range. This confers a significant advantage over a dispersive spectrometer, which measures intensity over a narrow range of wavelengths at a time. The term Fourier-transform infrared spectroscopy originates from the fact that a Fourier transform (a mathematical process) is required to convert the raw data into the actual spectrum. Attenuated total reflection (ATR) is a sampling technique used in conjunction with infrared spectroscopy, which enables samples to be examined directly in the solid or liquid state without further preparation.

The investigators developed disposable sample slides that allowed the rapid preparation and analysis of multiple samples, enabling high-throughput ATR-FTIR spectroscopy optimized for clinical research. Based upon the design of a microscope slide, these optical sample slides contained four sample areas; one for background measurements and three for repeat measurements of a single patient. This device was developed for the triplicate measurement of patient samples with optimized spectral throughput and performance.

The investigators described the transition to this technology for the established application of ATR-FTIR spectroscopy of blood serum for the detection of brain cancer, and the subsequent impact on clinical diagnostics. In the current study, they analyzed samples from a prospective cohort of 104 patients and found that the blood test was able to differentiate cancer and control patients at a sensitivity and specificity of 93.2% and 92.8%, respectively.

Senior author Dr. Matthew J. Baker, reader in pure and applied chemistry at Strathclyde University and CSO at ClinSpec Diagnostics, said, "This is the first publication of data from our clinical feasibility study and it is the first demonstration that our blood test works in the clinic. Earlier detection of brain tumors in the diagnostic pathway brings the potential to significantly improve patient quality of life and survival, whilst also providing savings to the health services."

The clinical feasibility study was published in the October 8, 2019, online edition of the journal Nature Communications.

Related Links:
University of Strathclyde
ClinSpec Diagnostics Limited


Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Microscope
dIFine
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.